The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Journal of Pharmaceutical Policy and Practice
(Dec 2015)
Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
Hedi Schelleman,
Rudy Dupree,
Finn B Kristensen,
Wim Goettsch
Affiliations
Hedi Schelleman
National health Care Institute, Diemen Zuid, 1112 XH, the Netherlands.
Rudy Dupree
National health Care Institute, Diemen Zuid, 1112 XH, the Netherlands.
Finn B Kristensen
University of Southern Denmark, Copenhagen, 1399, Denmark.
Wim Goettsch
National health Care Institute, Diemen Zuid, 1112 XH, the Netherlands.
DOI
https://doi.org/10.1186/2052-3211-8-S1-O13
Journal volume & issue
Vol. 8, no. sup1
Abstract
Read online
No abstracts available.
Keywords
Health Technology Assessment
Success Factor
Eastern European Country
Sofosbuvir
Promising Agent
WeChat QR code
Close